The Week in Brief
- S&P 500 rose 2.6% and Nasdaq-100 gained 3.6%, with 1,318 advancers against 573 decliners
- Energy led all sectors with a 5.4% gain; 86 of 95 energy stocks advanced
- AMD rose 18.9% and AVGO gained 18.2% while NVDA fell 12.8% following CEO resignation news
- Gold dropped 4.6% and long-term Treasuries fell 3.1% as risk assets rallied
Major equity indices rose across the board, with the Nasdaq-100 leading at 3.6% and the S&P 500 adding 2.6%. The rally showed solid breadth, with 1,318 stocks advancing against 573 decliners. Small-cap stocks lagged while long-duration Treasuries fell 3.1%.
Index & Asset Scoreboard
Weekly price change of the major index and asset-class ETFs, Friday close to Friday close.
| Instrument | Nov 13 close | Week |
|---|---|---|
| S&P 500 (SPY) | $754.21 | ▲+2.56% |
| Nasdaq-100 (QQQ) | $679.89 | ▲+3.63% |
| Dow Jones (DIA) | $523.15 | ▲+2.13% |
| Russell 2000 (IWM) | $277.54 | ▲+1.43% |
| 20+ Yr Treasuries (TLT) | $79.38 | ▼-3.10% |
| Gold (GLD) | $355.45 | ▼-4.60% |
| Crude Oil (USO) | $145.58 | ▼-1.91% |
Sector Rotation
Energy led the sector table with a 5.4% gain, supported by 86 of 95 constituent stocks advancing. Industrials and technology followed, rising 3.7% and 3.3% respectively, while real estate and materials lagged at the bottom of the table.
Left: the ten SPDR sector ETFs ranked by weekly price change. Right: breadth inside each sector across the screened universe: how many of its stocks rose, and the average move.
| Sector ETF | Week |
|---|---|
| Energy (XLE) | ▲+5.37% |
| Industrials (XLI) | ▲+3.74% |
| Technology (XLK) | ▲+3.33% |
| Financials (XLF) | ▲+2.66% |
| Consumer Staples (XLP) | ▲+2.52% |
| Health Care (XLV) | ▲+2.19% |
| Utilities (XLU) | ▲+2.11% |
| Consumer Disc. (XLY) | ▲+2.04% |
| Real Estate (XLRE) | ▲+0.84% |
| Materials (XLB) | ▲+0.52% |
| Sector (stocks) | Adv / Total | Avg move |
|---|---|---|
| Energy | 86 / 95 | +5.81% |
| Information Technology | 201 / 256 | +4.18% |
| Communication | 53 / 66 | +3.67% |
| Industrials | 241 / 307 | +3.24% |
| Consumer Staples | 66 / 86 | +1.59% |
| Utilities | 43 / 61 | +1.49% |
| Financials | 238 / 340 | +1.00% |
| Consumer Discretionary | 121 / 212 | +0.82% |
| Health Care | 169 / 280 | +0.25% |
| Real Estate | 56 / 107 | +0.07% |
| Materials | 44 / 91 | -0.11% |
Standout Movers
Industrials led the top gainers, with AAON, Inc. rising 40.3% after reporting an earnings beat. Advanced Micro Devices, Inc. gained 18.9% even as news reports noted NVIDIA Corporation CEO Jensen Huang resigned.
Health care stocks led declines despite mixed earnings results, with ImmunityBio, Inc. dropping 30.3% after an earnings miss. Strategy Inc fell 13.4% following news of its removal from the MSCI USA Index.
Biggest gainers
Biggest decliners
- 1JANXHealth CareJanux Therapeutics, Inc.▼-35.51%$11.37 · $1.1B
Reported earnings: EPS beat (+29.8% surprise)
- 2IBRXHealth CareImmunityBio, Inc.▼-30.28%$6.02 · $9.5B
Reported earnings: EPS miss (-111.8% surprise)
- 3IONSHealth CareIonis Pharmaceuticals, Inc.▼-26.28%$29.06 · $6.7B
Reported earnings: EPS beat (+46.4% surprise)
Top 10 Winners
Largest weekly gains among US-listed stocks with market cap above $1B and share price above $5. Context shows the week's earnings result and latest headline where available.
Biggest gainers · Nov 6–Nov 13
| Symbol | Week | Context |
|---|---|---|
| MODModine Manufacturing Company$135.66 | ▲+40.42% | — |
| AAONAAON, Inc.$80.25 | ▲+40.32% | EPS beat +41.9% |
| LQDALiquidia Corporation$57.41 | ▲+29.30% | EPS miss -814.8% |
| LGNLegence Corp.$35.00 | ▲+25.40% | EPS beat +76.4% |
| LUNRIntuitive Machines Inc$13.00 | ▲+24.16% | EPS beat +19.6% |
| CECOCECO Environmental Corp.$54.25 | ▲+24.11% | EPS miss -0.9% |
| CORZCore Scientific Inc$14.52 | ▲+23.47% | — |
| AMBQAmbiq Micro, Inc.$47.46 | ▲+23.08% | EPS beat +69.1% |
| FLYFirefly Aerospace Inc.$25.21 | ▲+21.44% | EPS beat +6.8% |
| TTDThe Trade Desk, Inc.$15.68 | ▲+21.27% | EPS beat +28.8% |
Top 10 Losers
Largest weekly declines on the same screen.
Biggest decliners · Nov 6–Nov 13
| Symbol | Week | Context |
|---|---|---|
| JANXJanux Therapeutics, Inc.$11.37 | ▼-35.51% | EPS beat +29.8% |
| IBRXImmunityBio, Inc.$6.02 | ▼-30.28% | EPS miss -111.8% |
| IONSIonis Pharmaceuticals, Inc.$29.06 | ▼-26.28% | EPS beat +46.4% |
| HIMSHims & Hers Health, Inc.$19.73 | ▼-24.12% | EPS miss -254.1% |
| EVCMEverCommerce Inc$6.33 | ▼-22.99% | — |
| NVAXNovavax, Inc.$8.53 | ▼-20.92% | — |
| CTVACorteva, Inc.$9.43 | ▼-20.76% | EPS miss -38.1% |
| VIRVir Biotechnology, Inc.$9.96 | ▼-18.43% | — |
| RGTIRigetti Computing, Inc.$9.62 | ▼-18.13% | EPS miss -14.7% |
| ARWRArrowhead Pharmaceuticals, Inc.$47.78 | ▼-17.85% | EPS miss -87.8% |
Large-Cap Movers
The same ranking restricted to companies above $50B in market cap: the names most likely to sit in index funds and 401(k)s.
Large-cap gainers
- AMDAdvanced Micro Devices, Inc. · $875.9B▲+18.93%
- AVGOBroadcom Inc · $1.56T▲+18.16%
- MPWRMonolithic Power Systems Inc · $58.1B▲+16.81%
- ANETArista Networks, Inc. · $249.3B▲+15.51%
- STXSeagate Technology Holdings PLC · $115.2B▲+14.60%
Large-cap decliners
- MSTRStrategy Inc · $54.5B▼-13.43%
- NVDANVIDIA Corporation · $4.01T▼-12.75%
- MRNAModerna, Inc. · $101.5B▼-12.12%
- NEMNewmont Corporation · $125.6B▼-6.43%
- SYKStryker Corporation · $123.5B▼-4.98%
Earnings Movers
Earnings reactions diverged sharply from headline results, with several companies posting large moves counter to their beat-or-miss status. AAON, Inc. rose 40.3% after an earnings beat, while Liquidia Corporation gained 29.3% despite a miss.
213 companies in the screen reported quarterly results this week. These are the largest weekly moves among them, with the EPS surprise that accompanied them.
Biggest gains after reporting
| Symbol | Act / Est | Surprise | Week |
|---|---|---|---|
| AAONAAON, Inc. | $0.83$0.58 | +41.9% | ▲+40.32% |
| LQDALiquidia Corporation | $-6.99$0.98 | -814.8% | ▲+29.30% |
| LGNLegence Corp. | $1.15$0.65 | +76.4% | ▲+25.40% |
| LUNRIntuitive Machines Inc | $-0.10$-0.12 | +19.6% | ▲+24.16% |
| CECOCECO Environmental Corp. | $0.60$0.61 | -0.9% | ▲+24.11% |
Biggest declines after reporting
| Symbol | Act / Est | Surprise | Week |
|---|---|---|---|
| JANXJanux Therapeutics, Inc. | $-0.34$-0.48 | +29.8% | ▼-35.51% |
| IBRXImmunityBio, Inc. | $-0.18$-0.09 | -111.8% | ▼-30.28% |
| IONSIonis Pharmaceuticals, Inc. | $-0.66$-1.23 | +46.4% | ▼-26.28% |
| HIMSHims & Hers Health, Inc. | $-0.10$0.06 | -254.1% | ▼-24.12% |
| CTVACorteva, Inc. | $0.06$0.10 | -38.1% | ▼-20.76% |
Methodology & Disclaimer
Data. All figures come from Money365.Market's own daily price, earnings and analyst-recommendation records, captured at each US close. Returns are price returns from the Nov 6 close to the Nov 13 close; dividends are excluded.
Screen. 1,902 US-listed common stocks with market capitalization of at least $1B and a closing price of at least $5, with prices on at least three of the week's 5 trading days. ETFs and funds are excluded from the stock rankings.
Adjustments. Weekly moves are compounded from daily changes and cross-checked against closing prices; where the two disagree (stock splits, data corrections) the smaller move is used and the row is marked with an asterisk.
Narrative. The short prose sections were drafted by an AI model from the verified data above only, then checked automatically for number and ticker traceability, editorial tone and FCA financial-promotion wording before publication.
Important Disclaimer — Not Investment Advice
Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.
Read the full disclaimer — 8 further points, including total-loss risk, our regulatory status and conflicts of interest
Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.
- You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
- Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
- Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
- Automated content. This brief was compiled by an automated pipeline from validated news and market-data sources and passed through editorial and compliance checks. Automated content can still contain errors — verify anything you intend to rely on.
- We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
- Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
- Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.
Full terms: Disclaimer · Terms of Service · Privacy Policy